AzTrials
AzTrials

HepatolithiasisNCT03098251

Effect of 3D Typing on Surgical Treatment of Hepatolithiasis

A study testing 3D typing and routine typing in people with Hepatolithiasis and Surgery, run by Southwest Hospital, China at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

According to a large amount of case affected with hepatolithiasis, we developed a typing system of Hepatolithiasis based on 3D digital conformation. And we hypothesized that it could predict a more precise construction of this disease, hence, typing by 3D conformation will improve the outcome of surgical treatment.The… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Hepatolithiasis, Surgery
What is being tested?
3D typing and routine typing
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteChina
Study dates
11 Apr 2017to 31 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged from 18 to 65 years old
  • Without gender restriction
  • With a favorable liver function of Child-Pugh A to B
  • No contraindications to surgery and anesthesia
  • Diagnosed with Hepatolithiasis and Signed informed consent.

Who cannot join

  • Diffused type of Hepatolithiasis
  • Impairment in liver function
  • Severe disorders in vital organ
  • Accompanied with tumors.

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Southwest Hospital

    Chongqing, Chongqing Municipality, 400038

    xiaobin Feng, MD

    Recruiting

Other trials in China

About this study

Official title: Efficacy of 3D Typing and Routine Typing on Surgical Treatment of Hepatolithiasis

According to a large amount of case affected with hepatolithiasis, we developed a typing system of Hepatolithiasis based on 3D digital conformation. And we hypothesized that it could predict a more precise construction of this disease, hence, typing by 3D conformation will improve the outcome of surgical treatment.The investigators will use a multicenter ambispective cohort study to test this hypothesis.

Read the detailed description

According to a large amount of case affected with hepatolithiasis, we developed a typing system of Hepatolithiasis based on 3D digital conformation. And we hypothesized that it could predict a more precise construction of this disease, hence, typing by 3D conformation will improve the outcome of surgical treatment.The investigators will use a multicenter ambispective cohort study to test this hypothesis. In this cohort study, two group will be enrolled to compare the outcomes.

Being tested
3D typing, routine typing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 3D typingProcedure or surgery

    typing the patient with 3D typing system and give specific treatment

  • routine typingProcedure or surgery

    typing the patient with routine typing system and give specific treatment

Study groups in NCT03098251
Study groupRoleWhat they receive
3D typingExperimentaltyping the patient with 3D typing system and give treatment according preestablished algorism in our center.
Receives: Procedure: 3D typing
routine typingActive comparatortyping the patient with routine typing system and give treatment according preestablished algorism in our center.
Receives: Procedure: routine typing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. residual ratio of biliary stone

    residual ratio of biliary stone diagnosed within 3 months

    Measured: 3 months

Secondary outcomes (4)
  1. postoperative complications

    postoperative complications diagnosed within 6 months

    Measured: 6 months

  2. residual lesions

    residual lesions diagnosed within 6 months

    Measured: 6 months

  3. Health economics index

    Health economics index within 3 months

    Measured: 3 months

  4. mortality

    mortality occured within 3 months

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Mar 2017
  2. Study start11 Apr 2017
  3. Primary completion30 Dec 2018 (estimated)
  4. Study completion31 Dec 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03098251
Sponsor's protocol ID
SWHB017
Status last verified
Apr 2017
First submitted
20 Mar 2017
Last updated
12 Apr 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing 3D typing and routine typing in people with Hepatolithiasis and Surgery, run by Southwest Hospital, China at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Xiaobin Feng, MD (+86-2368765297, fengxiaobin200708@aliyun.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

residual ratio of biliary stone (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in